The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 04, 2023
Filed:
Oct. 31, 2018
Applicant:
Janssen Biotech, Inc., Horsham, PA (US);
Inventors:
Tahamtan Ahmadi, Rydal, PA (US);
Christopher Chiu, Warren, NJ (US);
Ming Qi, Phoenixville, PA (US);
Amy Sasser, Doylestown, PA (US);
Jordan Schecter, Livingston, NJ (US);
Assignee:
JANSSEN BIOTECH, INC., Horsham, PA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61P 35/00 (2006.01); A61K 31/573 (2006.01); A61K 31/495 (2006.01); A61K 31/4439 (2006.01); A61K 31/69 (2006.01); A61K 9/00 (2006.01); A61K 31/454 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); A61K 9/0019 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/573 (2013.01); A61K 31/69 (2013.01); A61K 39/3955 (2013.01); A61P 35/00 (2018.01); A61K 31/495 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); C07K 2317/34 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01);
Abstract
Disclosed are methods of treating a subject having high-risk multiple myeloma, methods of achieving negative minimal residual disease status in a subject having multiple myeloma, and methods of predicting a likelihood of, or decreasing a risk of, relapse and/or disease progression in a subject having multiple myeloma.